3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, CD; Pratt, VS; Ryu, DY; Schut, HA; Snyderwine, EG | 1 |
1 other study(ies) available for 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine and Experimental Hepatoma
Article | Year |
---|---|
In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Topics: Animals; Carcinogens; DNA Adducts; Female; Lac Operon; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Transgenic; Mutagens; Quinoxalines; Sequence Analysis, DNA; Sex Factors | 1999 |